医薬品リファレンス
Lipegfilgrastim
Lipegfilgrastim is a medicine in the class miscellaneous. It is used for febrile neutropenia.
- 薬効分類: Miscellaneous
- 効能・効果: febrile neutropenia
最終更新日 出典: EMA SmPC
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Miscellaneous
- ATCコード
- L03AA14
- 一般的な規格
- 6 mg
- 商品名
- 2
- 国・市場
- 2
何に使われるか
作用のしくみ
Lipegfilgrastim is a PEGylated conjugate of filgrastim (recombinant methionyl human G-CSF) that binds the G-CSF receptor. It stimulates proliferation and differentiation of haematopoietic progenitor cells and release of neutrophils into the blood.
成人の通常用量（添付文書の要約）
Reduction in duration of neutropenia and febrile neutropenia with cytotoxic chemotherapy: 6 mg (0.6 ml), subcutaneous, once for each chemotherapy cycle, given approximately 24 hours after cytotoxic chemotherapy
妊娠と授乳
- 妊娠
- Unknown Very limited human data (fewer than 300 pregnancies); animal studies showed reproductive toxicity. UK label: as a precaution, preferably avoid in pregnancy. Filgrastim has more pregnancy data and may be preferred.
- 授乳
- Unknown Not known if it passes into milk. No LactMed record; related G-CSFs (filgrastim) pass poorly into milk and are not absorbed by the infant, but this long-acting form has no data. UK label: stop breastfeeding during treatment (risk cannot be excluded).
報告されている副作用
- Musculoskeletal pain
- Nausea
- Thrombocytopenia
- Hypokalaemia
- Headache
- Haemoptysis
禁忌
- Hypersensitivity to the active substance or to any excipient.
注意が必要な方
- Cross-reactivity: patients hypersensitive to G-CSF or derivatives should not start lipegfilgrastim.
- Not to be used to increase chemotherapy dose beyond established regimens; not investigated with high dose chemotherapy.
- Thrombocytopenia and leukocytosis may occur; monitor platelet count, haematocrit and WBC regularly.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Lipegfilgrastimの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Lipegfilgrastim used for?
Lipegfilgrastim is a medicine in the class miscellaneous. It is used for Febrile neutropenia, Neutropenia.
What side effects have been reported with Lipegfilgrastim?
Musculoskeletal pain, Nausea, Thrombocytopenia, Hypokalaemia, Headache, Haemoptysis.
Can Lipegfilgrastim be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Very limited human data (fewer than 300 pregnancies); animal studies showed reproductive toxicity. UK label: as a precaution, preferably avoid in pregnancy. Filgrastim has more pregnancy data and may be preferred. Breastfeeding: Unknown. Not known if it passes into milk. No LactMed record; related G-CSFs (filgrastim) pass poorly into milk and are not absorbed by the infant, but this long-acting form has no data. UK label: stop breastfeeding during treatment (risk cannot be excluded).
What does Lipegfilgrastim interact with?
MediHelp does not list a checked interaction for Lipegfilgrastim yet. Always tell your pharmacist about every medicine you take.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
